Surveillance Epidemiology of Coronavirus Under Research Exclusion (SECURE-IBD) is an international database to monitor and report on outcomes of COVID-19 occurring in IBD patients. IBD clinicians worldwide will report all cases of COVID-19 in their IBD patients, regardless of severity. With the collaboration of the IBD community, we will rapidly be able to define the impact of COVID-19 on patients with IBD and how factors such as age, comorbidities, and IBD treatments impact COVID outcomes.